This Article Abstract Full Text (PDF) All Versions of this Article: 115/1/34    most recent CIRCULATIONAHA.106.661868v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Djoussé, L. Articles by Gaziano, J. M. Search for Related Content PubMed PubMed Citation Articles by Djoussé, L. Articles by Gaziano, J. M. Pubmed/NCBI databases Medline Plus Health Information Alcohol Consumption Heart Failure Related Collections Epidemiology Congestive

(Circulation. 2007;115:34-39.)
© 2007 American Heart Association, Inc.

Epidemiology

Alcohol Consumption and Risk of Heart Failure in the Physicians’ Health Study I

From the Divisions of Aging (L.D., J.M.G.) and Preventive Medicine (J.M.G.), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Luc Djoussé, MD, MPH, DSc, Division of Aging, Brigham and Women’s Hospital and Harvard Medical School, 1620 Tremont St, 3rd Floor, Boston MA 02120. E-mail ldjousse{at}rics.bwh.harvard.edu

Received August 29, 2006; revision received October 18, 2006; accepted October 20, 2006.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— Heart failure (HF) is the leading cause of hospitalization among the elderly, and 1 in 5 adults aged 40 years will develop HF in their lifetime. Data on the effects of moderate alcohol consumption on the risk of HF have been sparse and inconsistent. This study sought to evaluate the association between moderate alcohol consumption and incident HF.

Methods and Results— A total of 21 601 participants of the Physicians’ Health Study I who were free of HF and provided data on alcohol intake at baseline were prospectively followed up from 1982 to 2005. Incident HF cases were ascertained through annual follow-up questionnaires and validated with the use of Framingham criteria. During an average follow-up of 18.4 years, 904 incident cases of HF occurred. The crude incidence rates of HF were 25.0, 20.0, 24.3, and 20.6 cases per 10 000 person-years for alcohol categories of <1, 1 to 4, 5 to 7, and >7 drinks per week, respectively. Corresponding hazard ratios (95% CI) were 1.0 (reference), 0.90 (0.76 to 1.07), 0.84 (0.71 to 0.99), and 0.62 (0.41 to 0.96), respectively, with P for trend=0.012 adjusted for age, body mass index, smoking, and history of valvular heart disease. There was no evidence for a strong association between moderate alcohol consumption and HF without antecedent coronary artery disease.

Conclusions— Although heavy drinking should be discouraged, our data indicate that moderate drinking may lower the risk of HF. The lack of an association between moderate alcohol intake and HF without antecedent coronary artery disease suggests that possible benefits of moderate drinking on HF may be mediated through beneficial effects of alcohol on coronary artery disease.

Key Words: alcohol • epidemiology • heart failure • risk factors

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
The lifetime risk of heart failure (HF) is estimated at 20% (1 in 5) for both men and women aged 40 years.¹ Although advanced age, hypertension, diabetes mellitus, obesity, valvular heart disease, and myocardial infarction have been recognized as predictors of HF,^2,3 limited data are available on the effects of modifiable lifestyle factors on the risk of HF. Specifically, epidemiological data on the role of moderate alcohol consumption on HF risk have been limited. Although heavy drinking has been associated with left ventricular dysfunction^4–6 and dilated cardiomyopathy,^7–10 only few studies have examined whether moderate alcohol consumption influences the risk of HF. Mukamal et al¹¹ did not find an association between recent alcohol consumption and HF. In the Survival and Ventricular Enlargement (SAVE) trial,¹² moderate alcohol consumption was associated with a lower incidence of HF in crude analyses but not in multivariable analyses of 2231 post–myocardial infarction patients with left ventricular systolic dysfunction. Contrary to these reports, data from the Framingham Heart Study have shown that moderate alcohol consumption was associated with a lower risk of HF.¹³ In addition, Abramson and colleagues¹⁴ have shown that consumption of 21 to 70 oz of alcohol per month was associated with a 47% reduction in HF risk after 14 years of follow-up among 2235 elderly subjects, and data from the Cardiovascular Health Study showed a lower risk of HF among moderate drinkers.¹⁵ Possible physiological mechanisms by which moderate alcohol consumption might lower the risk of HF include its beneficial effects on coronary artery disease (CAD) and neurohormonal changes that might prevent clinical onset of HF.^16–18 The present project sought to prospectively assess whether moderate alcohol consumption was associated with a lower risk of HF among US male physicians. In addition, we sought to determine whether moderate alcohol consumption influences the risk of HF without antecedent CAD.

Clinical Perspective p 39

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Study Population
The present study analyzed data from the Physicians’ Health Study (PHS) I, which was a randomized, double-blind, placebo-controlled trial in which a 2x2 factorial design was used to study low-dose aspirin and beta carotene for the primary prevention of cardiovascular disease and cancer among US male physicians. A detailed description of the PHS I has been published previously.¹⁹ Briefly, in 1981, 261 248 US male physicians aged 40 to 85 years were invited to participate in the trial. After exclusion criteria (history of myocardial infarction, stroke, transient ischemic attack, cancer [except nonmelanoma skin cancer], gout, current liver or kidney disease, peptic ulcer, current use of trial treatments), 33 223 participants were enrolled in an 18-week run-in period. After the run-in period, 22 071 subjects were randomized to low-dose aspirin, beta carotene, both agents, or placebo. For the present project, we excluded 470 participants because of (1) missing information on baseline alcohol (n=198), (2) prevalent HF (n=18), and (3) missing covariates (n=254). Each participant gave written informed consent, and the study protocol was approved by the institutional review board at Brigham and Women’s Hospital, Boston, Mass.

Alcohol Consumption
Information about usual alcohol consumption was self-reported on a standard questionnaire. Participants were asked, "How often do you usually consume alcoholic beverages?" Possible response categories included "rarely/never," "1 to 3/mo," "1/wk," "2 to 4/wk," "5 to 6/wk," "daily," and "2+/d." The response was interpreted as number of alcoholic drinks consumed during the specified period.

Ascertainment of Incident HF
A questionnaire was mailed to each participant every 6 months during the first year and has been mailed annually thereafter to obtain information on compliance with the intervention and the occurrence of new medical diagnoses including HF. In a pilot study, a total of 100 participants who reported a HF diagnosis on a follow-up questionnaire were contacted by mail. The mailing included a HF questionnaire with detailed questions about time and place of HF diagnosis, clinical signs and symptoms, medical treatment, and diagnostic methods (echocardiography, angiography, and radionuclide imaging). Of the 100 physicians, 4 had died, and 8 participants had a routine follow-up method that deviates from the normal mailing procedure (eg, some participants have requested to be contacted by telephone only). After 2 mailings, we obtained a completed questionnaire from 73 of 88 participants (83%). Among respondents, 90% of the HF cases (66 of 73) were confirmed with the use of the Framingham criteria.²⁰

Other Variables
Information on age, height, weight, body mass index, cigarette smoking, parental history of myocardial infarction, history of angina, hypertension, atrial fibrillation, valvular disease, diabetes mellitus, and physical activity was collected at baseline. Incident CAD (angina pectoris, myocardial infarction, coronary angioplasty, and coronary bypass surgery) was ascertained through annual follow-up questionnaires.

Statistical Analyses
Because the initial analyses conducted with the original 7 alcohol categories showed an inverse association between alcohol consumption and HF (hazard ratio, 1.0, 0.99, 0.82, 0.91, 0.75, 0.81, 0.61 from the lowest to the highest category of alcohol intake, respectively, adjusted for age, smoking, and history of valvular heart disease; P for trend=0.005), we collapsed adjacent categories to obtain stable estimates. Additional adjustment for exercise (categories) did not alter the findings. We calculated person-time of follow-up from baseline until the first occurrence of (1) HF, (2) death, or (3) censoring date (date of receipt of last follow-up questionnaire). Within each alcohol category, incidence rate was computed by dividing the number of HF cases by the corresponding person-time. Actuarial analyses were performed by the Kaplan-Meier method, and the statistical significance was determined with the log-rank test. We used Cox proportional hazard models to compute multivariable adjusted hazard ratios with corresponding 95% CIs using subjects in the alcohol category of "rarely/never" as reference group. We assessed confounding by using 10% change in hazard ratio. Assumptions for the proportional hazard models were tested (by including main effects and product terms of covariates and time factor) and were met (all P>0.05). We obtained the probability value for linear trend by assigning the midpoint of each alcohol group to a new variable that was modeled as a continuous variable in the Cox regression model. A value of 9 was assigned to the highest open-ended alcohol category. Age was a major confounding factor, and because we did not have adequate overlap across categories of alcohol, we conducted stratified analyses by age categories (<50, 50 to 59, 60 to 69, and 70 years). In addition, we controlled for age as a continuous variable within age strata when fitting Cox regression models. Smoking was entered in the model as never, past, and current smoker. We also examined whether the effects of alcohol were mediated by myocardial infarction by adjusting additionally for myocardial infarction as a time-dependent covariate. We updated myocardial infarction at the end of 1989, 1994, and 1999. To assess whether alcohol influences the risk of HF without antecedent CAD, we censored noncases at the time of diagnosis of CAD. HF cases that occurred after CAD were also censored at the time of diagnosis of CAD and recoded as noncases. To examine a possible "sick quitter" effect (subjects may have stopped drinking shortly after a diagnosis of a chronic condition), we conducted sensitivity analyses by excluding individuals whose person-times were <2 years and by using people consuming 1 to 4 drinks per week as the reference group. We also verify that alcohol intake was inversely related to myocardial infarction in this cohort. All analyses were completed with the use of SAS, version 9.1 (SAS Institute, NC). The significance level was set at 0.05.

The authors had full access to the data and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Among 21 601 participants in the PHS I, the mean age at randomization was 53.8±9.5 years (range, 40 to 86 years). Table 1 presents baseline characteristics of the study participants. Frequent alcohol consumption was associated with older age; current smoking; higher prevalence of hypertension, atrial fibrillation, and valvular disease; and lower prevalence of angina pectoris and diabetes mellitus. During an average follow-up of 18.4 years, 904 new cases of HF occurred. The crude incidence rates of HF were 25.0, 20.0, 24.3, and 20.6 cases per 10 000 person-years for usual alcohol consumption of <1, 1 to 4, 5 to 7, and >7 drinks per week, respectively. There was evidence for increased event-free survival from the lowest to the highest category of alcohol consumption (P=0.02, log-rank test). From the multivariable Cox regression model, hazard ratios (95% CI) for HF were 1.0 (reference), 0.88 (0.75 to 1.05), 0.80 (0.68 to 0.94), and 0.62 (0.40 to 0.95) for alcohol consumption of <1, 1 to 4, 5 to 7, and >7 drinks per week, respectively, after adjustment for age and smoking (3 categories) (P for linear trend=0.002; Table 2). Additional adjustment for body mass index (<25, 25 to 29, 30 kg/m²) and history of valvular heart disease had only a minimal effect on the results (Table 2). Further adjustment for physical activity did not alter these findings (data not shown). Additional adjustment for myocardial infarction, as a time-dependent covariate, led to a modest attenuation of the main effect of alcohol on HF: Corresponding hazard ratios (95% CI) were 1.0, 0.91 (0.76 to 1.07), 0.87 (0.73 to 1.02), and 0.63 (0.41 to 0.97) from the lowest to the highest alcohol group (P for trend=0.02). Exclusion of individuals whose follow-up times were <2 years made the association slightly stronger with fully adjusted relative risks (95% CI): 1.0, 0.90 (0.76 to 1.06), 0.83 (0.70 to 0.99), and 0.58 (0.37 to 0.91) from the lowest to the highest alcohol category, respectively (P for trend=0.007). When we used drinkers of 1 to 4 per week as the reference group, our data showed similar results. Multivariable adjusted relative risks (95% CI) were 1.11 (0.94 to 1.32), 1.0 (reference), 0.94 (0.80 to 1.10), and 0.69 (0.45 to 1.06) from the lowest to the highest alcohol group, respectively (P for trend=0.003).

Of the total of 904 incident cases of HF, 143 (15.8%) and 346 (38.3%) had antecedent myocardial infarction and CAD, respectively. We examined the association between alcohol intake and HF without antecedent CAD and found no evidence for a strong association. Compared with the lowest alcohol category, hazard ratios (95% CI) for HF without antecedent CAD were 0.93 (0.74 to 1.16), 0.97 (0.79 to 1.21), and 0.84 (0.51 to 1.37) in subjects consuming 1 to 4, 5 to 7, and >7 drinks per week, respectively (P for trend=0.73; Table 3). There was evidence for a weaker inverse association between moderate alcohol intake and HF without antecedent myocardial infarction (hazard ratio, 1.0, 0.93 [95% CI, 0.77 to 1.12], 0.91 [95% CI, 0.76 to 1.09], and 0.66 [95% CI, 0.10 to 1.04] from the lowest to the highest alcohol category, respectively; P for trend=0.13). In a multivariable model adjusted for age, body mass index, smoking, and history of hypertension, atrial fibrillation, and valvular heart disease, alcohol consumption was inversely associated with the risk of myocardial infarction in this cohort with corresponding hazard ratio (95% CI) of 1.0, 0.86 (0.76 to 0.98), 0.67 (0.59 to 0.77), and 0.61 (0.43 to 0.86) from the lowest to the highest category of alcohol, respectively (P for trend <0.0001). In secondary analyses, moderate alcohol consumption was associated with a lower risk of HF (although this was not statistically significant) in people with and without diabetes (data not presented). Furthermore, we did not find evidence for an interaction between moderate alcohol consumption and diabetes on the risk of HF (P for interaction=0.53).

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
In observational studies, moderate alcohol consumption has been associated with lower rates of coronary heart disease,^21–23 a major determinant of HF. Although many researchers have shown that heavy alcohol consumption is associated with cardiomyopathy,^10,24 limited data are available on the influence of moderate alcohol consumption (up to 2 drinks per day for men and 1 drink per day for women) on the development of HF in a community setting. In the present prospective study, we demonstrated that moderate alcohol consumption was inversely associated with the risk of HF in a dose-response manner and independent of major confounding factors. We did not find a statistically significant association between moderate alcohol consumption and HF without antecedent CAD, however.

Our findings are consistent with many of the previously published data suggesting a reduced risk of HF with moderate alcohol consumption. Abramson et al¹⁴ first reported an inverse association between alcohol consumption and HF among 2235 elderly subjects with a mean age of 74 years; in that cohort, alcohol intake was inversely associated with HF incidence (P for trend=0.02) with a 47% lower risk of HF in subjects consuming 21 to 70 oz of alcohol per month (1.5 to 4 drinks per day) compared with abstainers.¹⁴ We have previously reported an inverse association between alcohol consumption and all-cause incident HF in 2796 men and 3493 women of the Framingham Heart Study who reported light to moderate amounts of alcohol consumption¹³; in addition, the Framingham data showed a lower risk of HF without antecedent myocardial infarction among men who consumed 1 to 7 drinks per week (relative risk, 0.41 [95% CI, 0.21 to 0.79]) and suggestive evidence for women consuming 3 to 7 drinks per week (relative risk, 0.55 [95% CI, 0.25 to 1.20]) after adjustment for age, smoking, body mass index, diabetes, valvular disease, and hypertension. Recent data from the Cardiovascular Health Study found a 34% lower risk of HF among elderly people consuming 7 to 13 drinks per week but little effect with heavy alcohol consumption.¹⁵

In contrast, data from the Kaiser Permanente Medical care Program reported 40% to 60% lower risk of HF hospitalization for drinkers of at least 1 drink per day among 126 235 individuals.²⁵ This apparent risk reduction for HF hospitalization was restricted to CAD-related HF with only a borderline statistically significant 20% reduction in HF hospitalization risk among individuals consuming <1 drink per day. In contrast, heavy alcohol consumption was associated with a significant increased risk of non–CAD-related HF hospitalization in that cohort (relative risk, 1.7 [95% CI, 1.1 to 2.6]). Specifically, among 55 658 male participants in the Kaiser Permanente Study, consumption of 1 to 2 drinks per day was associated with 40% lower risk of CAD-related HF hospitalization (P=0.001) and a modest 10% increased risk of non–CAD-related HF hospitalization (P=0.7). Our study did not find a statistically significant association between moderate alcohol consumption and HF without antecedent CAD.

On the other hand, other investigators did not find an association between alcohol intake and HF. In a sample of subjects with myocardial infarction, recent alcohol consumption was associated with HF in a crude model, but this association became statistically nonsignificant after controlling for potential confounders.¹¹ In the SAVE trial, light to moderate alcohol consumption was not related to incident HF after 42 months of follow-up among 2231 patients with left ventricular systolic dysfunction who were randomized to angiotensin-converting enzyme inhibitor or placebo.¹² The discrepancy with our findings merits some comments. Whereas we assessed long-term alcohol consumption, Mukamal et al¹¹ assessed the immediate effects of alcohol on HF, namely, whether alcohol ingestion can trigger the development of HF. The PHS I included subjects with normal left ventricular function in contrast to the SAVE trial,¹² in which subjects had an ejection fraction <40%. In addition, the shorter mean follow-up in the SAVE trial (3.5 years compared with 19 years in the PHS I) and relative small sample size may have been insufficient for observation of any major effects of alcohol.

There are several biological mechanisms to explain the observed association between alcohol consumption and HF. Previous studies have demonstrated beneficial effects of alcohol on high-density lipoprotein cholesterol,^26,27 insulin sensitivity,^28,29 inflammation and endothelial function,³⁰ coagulation factors,³¹ and atrial natriuretic peptide,^16–18 a cardiac hormone that plays a role in volume homeostasis. Consequently, several studies have reported that moderate alcohol intake may lower the risk of myocardial infarction and fatal coronary events. The attenuation of the hazard ratios on additional adjustment for myocardial infarction and the lack of an association between moderate alcohol intake and HF without antecedent CAD suggest that the observed lower risk of HF among moderate drinkers may be mediated through beneficial effects of alcohol on CAD.

The present study has some limitations. First, we did not collect data to allow separation of former drinkers from lifetime abstainers. The inclusion of former drinkers who stopped drinking because of HF-related events would increase the baseline rate of HF in the reference category and thus inflate the alcohol-HF association. The fact that exclusion of HF cases occurred during the first 2 years of follow-up did not alter our results suggests that we did not have a substantial number of presymptomatic HF cases who reduced or stopped alcohol consumption to be wrongfully classified with lifetime abstainers. Furthermore, the fact that using moderate drinkers as the reference group still showed lower risk of HF for subjects consuming 5 to 7 and >7 drinks per week suggests that our findings are not influenced by sick quitters. Second, we did not collect adequate data to further classify HF on the basis of left ventricular function. Third, there is a possibility of underreporting of alcohol consumption, especially among heavy drinkers, because these data were self-reported. Such exposure misclassification in the highest alcohol group would lead to attenuation of the effects of moderate alcohol consumption on HF. Fourth, our sample consists of highly educated male physicians who may have different behaviors than the general population. It is thus possible that residual confounding in this cohort by unmeasured factors such as diet may partially explain our findings. The nature of our cohort also limits the generalizability of our findings. Fifth, because only 3% (n=665) of our participants reported consumption of 2 drinks per day, we did not have enough data to examine the effects of heavy drinking on HF, and our findings are mainly applicable to moderate drinkers. Finally, we did not have data on beverage types to examine the effects of wine, beer, and spirits consumption on HF. Nevertheless, the large sample size, the longer duration of follow-up, and the fact that participants were physicians who could recognize early signs of HF are strengths of the present study.

In conclusion, our data show an inverse association between moderate alcohol consumption and incident HF. Although individuals always need to be cautioned against the dangers of heavy alcohol drinking, these findings suggest that moderate alcohol consumption may lower the risk of HF, especially CAD-related HF.

	Acknowledgments

 
We are indebted to the participants in the PHS for their outstanding commitment and cooperation and to the entire PHS staff for their expert and unfailing assistance.

Sources of Funding

The PHS is supported by grants CA-34944 and CA-40360 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Md. Dr Djoussé is Principal Investigator on grant K01 HL-70444 from the National Heart, Lung, and Blood Institute, Bethesda, Md.

Disclosures

Dr Djoussé received an investigator-initiated research grant (grant-in-aid) from the Alcoholic Beverage Medical Research Foundation (January 2001 to December 2001) to study the effect of alcohol on lung cancer in the Framingham Heart Study. Dr Gaziano has received investigator-initiated research grants from BASF, DSM Pharmaceuticals, Wyeth Pharmaceuticals, McNeil Consumer Products, and Pliva; has received honoraria from Bayer and Pfizer for speaking engagements; and is a consultant for Bayer, McNeil Consumer Products, Wyeth Pharmaceuticals, Merck, Nutraquest, and GlaxoSmithKline.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002; 106: 3068–3072.[CrossRef][Medline] [Order article via Infotrieve]
   
2. Lloyd-Jones DM. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep. 2001; 3: 184–190.[Medline] [Order article via Infotrieve]
   
3. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G. Heart failure in the general population of men: morbidity, risk factors and prognosis. J Intern Med. 2001; 249: 253–261.[CrossRef][Medline] [Order article via Infotrieve]
   
4. Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989; 320: 409–415.[Abstract]
   
5. Bertolet BD, Freund G, Martin CA, Perchalski DL, Williams CM, Pepine CJ. Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population. Drug Alcohol Depend. 1991; 28: 113–119.[CrossRef][Medline] [Order article via Infotrieve]
   
6. Kupari M, Koskinen P, Suokas A. Left ventricular size, mass and function in relation to the duration and quantity of heavy drinking in alcoholics. Am J Cardiol. 1991; 67: 274–279.[CrossRef][Medline] [Order article via Infotrieve]
   
7. Rubin E, Urbano-Marquez A. Alcoholic cardiomyopathy. Alcohol Clin Exp Res. 1994; 18: 111–114.[CrossRef][Medline] [Order article via Infotrieve]
   
8. McKenna CJ, Codd MB, McCann HA, Sugrue DD. Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study. Am Heart J. 1998; 135: 833–837.[CrossRef][Medline] [Order article via Infotrieve]
   
9. Waldenstrom A. Alcohol and congestive heart failure. Alcohol Clin Exp Res. 1998; 22: 315S–317S.[CrossRef][Medline] [Order article via Infotrieve]
   
10. Piano MR. Alcohol and heart failure. J Card Fail. 2002; 8: 239–246.[CrossRef][Medline] [Order article via Infotrieve]
    
11. Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Lack of effect of recent alcohol consumption on the course of acute myocardial infarction. Am Heart J. 1999; 138: 926–933.[CrossRef][Medline] [Order article via Infotrieve]
    
12. Aguilar D, Skali H, Moye LA, Lewis EF, Gaziano JM, Rutherford JD, Hartley LH, Randall OS, Geltman EM, Lamas GA, Rouleau JL, Pfeffer MA, Solomon SD. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. J Am Coll Cardiol. 2004; 43: 2015–2021.[Abstract/Free Full Text]
    
13. Walsh CR, Larson MG, Evans JC, Djousse L, Ellison RC, Vasan RS, Levy D. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2002; 136: 181–191.[Abstract/Free Full Text]
    
14. Abramson JL, Williams SA, Krumholz HM, Vaccarino V. Moderate alcohol consumption and risk of heart failure among older persons. JAMA. 2001; 285: 1971–1977.[Abstract/Free Full Text]
    
15. Bryson CL, Mukamal KJ, Mittleman MA, Fried LP, Hirsch CH, Kitzman DW, Siscovick DS. The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol. 2006; 48: 305–311.[Abstract/Free Full Text]
    
16. Gianoulakis C, Guillaume P, Thavundayil J, Gutkowska J. Increased plasma atrial natriuretic peptide after ingestion of low doses of ethanol in humans. Alcohol Clin Exp Res. 1997; 21: 162–170.[CrossRef][Medline] [Order article via Infotrieve]
    
17. Colantonio D, Casale R, Desiati P, De Michele G, Mammarella M, Pasqualetti P. A possible role of atrial natriuretic peptide in ethanol-induced acute diuresis. Life Sci. 1991; 48: 635–642.[CrossRef][Medline] [Order article via Infotrieve]
    
18. Djousse L, Hunt CS, Eckfeldt JH, Arnett DK, Province MA, Ellison CR. Alcohol consumption and plasma atrial natriuretic peptide (from The HyperGEN Study). Am J Cardiol. 2006; 98: 628–632.[CrossRef][Medline] [Order article via Infotrieve]
    
19. Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med. 1989; 321: 129–135.[Abstract]
    
20. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 88: 107–115.[Medline] [Order article via Infotrieve]
    
21. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev. 1993; 15: 328–351.[Free Full Text]
    
22. Camargo CA Jr, Stampfer MJ, Glynn RJ, Grodstein F, Gaziano JM, Manson JE, Buring JE, Hennekens CH. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med. 1997; 126: 372–375.[Abstract/Free Full Text]
    
23. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA. 2001; 285: 1965–1970.[Abstract/Free Full Text]
    
24. Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest. 2002; 121: 1638–1650.
    
25. Klatsky AL, Chartier D, Udaltsova N, Gronningen S, Brar S, Friedman GD, Lundstrom RJ. Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease. Am J Cardiol. 2005; 96: 346–351.[CrossRef][Medline] [Order article via Infotrieve]
    
26. Haskell WL, Camargo C Jr, Williams PT, Vranizan KM, Krauss RM, Lindgren FT, Wood PD. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions: a controlled study. N Engl J Med. 1984; 310: 805–810.[Abstract]
    
27. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993; 329: 1829–1834.[Abstract/Free Full Text]
    
28. Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels: the Normative Aging Study. Am J Epidemiol. 1997; 145: 909–916.[Abstract/Free Full Text]
    
29. Greenfield JR, Samaras K, Hayward CS, Chisholm DJ, Campbell LV. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab. 2005; 90: 661–672.[Abstract/Free Full Text]
    
30. Shai I, Rimm EB, Schulze MB, Rifai N, Stampfer MJ, Hu FB. Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia. 2004; 47: 1760–1767.[CrossRef][Medline] [Order article via Infotrieve]
    
31. Torres Duarte AP, Dong QS, Young J, Abi-Younes S, Myers AK. Inhibition of platelet aggregation in whole blood by alcohol. Thromb Res. 1995; 78: 107–115.[CrossRef][Medline] [Order article via Infotrieve]
    

	Footnotes

 
Guest Editor for this article was Gregory L. Burke, MD, MSc.

This article has been cited by other articles:

				M. L. Balestrieri, C. Schiano, F. Felice, A. Casamassimi, A. Balestrieri, L. Milone, L. Servillo, and C. Napoli Effect of Low Doses of Red Wine and Pure Resveratrol on Circulating Endothelial Progenitor Cells J. Biochem., February 1, 2008; 143(2): 179 - 186. [Abstract] [Full Text] [PDF]

				L. Djousse and J. M. Gaziano Egg Consumption and Risk of Heart Failure in the Physicians' Health Study Circulation, January 29, 2008; 117(4): 512 - 516. [Abstract] [Full Text] [PDF]

				L. Djousse and J. M. Gaziano Breakfast Cereals and Risk of Heart Failure in the Physicians' Health Study I Arch Intern Med, October 22, 2007; 167(19): 2080 - 2085. [Abstract] [Full Text] [PDF]

				J. H. O'Keefe, K. A. Bybee, and C. J. Lavie Alcohol and Cardiovascular Health: The Razor-Sharp Double-Edged Sword J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1009 - 1014. [Abstract] [Full Text] [PDF]

				R. A. Kloner and S. H. Rezkalla To Drink or Not to Drink? That Is the Question Circulation, September 11, 2007; 116(11): 1306 - 1317. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 115/1/34    most recent CIRCULATIONAHA.106.661868v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Djoussé, L. Articles by Gaziano, J. M. Search for Related Content PubMed PubMed Citation Articles by Djoussé, L. Articles by Gaziano, J. M. Pubmed/NCBI databases Medline Plus Health Information Alcohol Consumption Heart Failure Related Collections Epidemiology Congestive